Description

MyHep DVir (Daclastasvir 60mg/Sofosbuvir 400mg)
MyHep DVIR™ is a fixed-dose combination licensed generic of Sovaldi® + Daklinza® produced in an FDA approved manufacturing facility in India. It’s a direct-acting antiviral (DAA) medication used to treat chronic Hepatitis C across all genotypes. For most patients, 12 weeks of treatment is needed to reach cure.
Bottle Size : 28 Tablets (4 weeks supply)
Active Ingredients : Sofosbuvir 400 mg + Daclatasvir 60 mg
Produced by Mylan Pharmaceuticals®
 
Description Credit: Link